We here are dedicated to identifying the upstream regulators of Raf/ERK signaling that are functionally next to EGFR, demonstrating the clinical potential of PTPLAD1 in regulating PHB-Raf interaction to repress CRC metastasis. This evidence concerns the gene HACD3 and colorectal carcinoma.